Your fact-checks will appear here
Clinical testing of ivermectin in human oncology is extremely limited and concentrated in early-phase trials for metastatic triple‑negative breast cancer (mTNBC), notably a phase I/II (sometimes repor...
Patient advocacy communities and a small but vocal set of clinics have amplified interest in repurposing through testimony-driven social media groups, celebrity mentions, patient-focused platforms, an...
PSA and DRE are useful screening tools but cannot reliably tell prostatitis from prostate cancer on their own; prostate biopsy remains the diagnostic gold standard and mpMRI substantially improves pre...